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In The Netherlands, many patients are being switched from atorvastatin to generic 
simvastatin at inferior doses, which might lead to a signiﬁcant increase in future 
cardiovascular events.
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OBJECTIVES: The objective of this study is the analysis of cardiovascular drugs 
consumption (C group) in two mid European countries, Croatia and Slovenia, for the 
9-year period (from 2000 to 2008). Further, the aim was to identify the generic drugs 
usage in each country, the price for DDD for original and generic drugs, and to identify 
the most prescribed drugs in C group. METHODS: The data on the consumption 
have been obtained from the International Medical Statistics database for Croatia and 
Slovenia. Drugs usage is presented in deﬁned daily doses per 1000 inhabitants per day 
(DDD/1000) according to the World Health Organization Collaborating Centre for 
Drugs Statistics Methodology. Financial expenditure data are presented in Euros. An 
average cost per DDD was calculated for each drug group. RESULTS: The total usage 
of cardiovascular drugs is higher in Slovenia, but the prescribed generic drugs usage 
is higher in Croatia during the investigated period i.e. in Croatia 65.07% of all pre-
scribed drugs from C group were generics in 2008., while in Slovenia it was 55.05%. 
The average price per 1 DDD, for both original and generic drugs in C group, was 
lower in Croatia. The cardiovascular drugs usage, according to C subgroups shows a 
higher prescription rate in Croatia for C01 (Cardiac therapy), C02 (Antihypertensives) 
and C09 (Agents acting on the renin-angiotensin system), while in Slovenia there is a 
higher consumption in C08 (Calcium channel blockers) and C10 (Lipid modifying 
agents). CONCLUSIONS: Comparing the cardiovascular drugs prices in both coun-
tries, there is a possibility for price reduction in Slovenia. Drugs prescription patterns 
are different in Croatia and Slovenia. This indicates the need for a more thorough 
analysis and the introduction of national drugs guidelines for rational prescribing, 
monitoring and evaluation. Although the generic drugs usage in C group is relatively 
high, it should be further supported and promoted.
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OBJECTIVES: Regular physical activity is a critical guideline-recommended compo-
nent of disease management in all patients with hypertension. We examined the 
associations of health care expenditure and resource use with physical inactivity in 
this population. METHODS: We used a nationally-representative sample from the 
2006 Agency for Health care Research and Quality Medical Expenditure Panel 
Survey(MEPS) for this retrospective study of adults (18 years or older) with a diagnosis 
of primary hypertension (ICD-9:401.x). Generalized linear modeling was used to 
assess all-cause total and out-of-pocket health care expenses and the odds of emer-
gency room visits and hospitalizations using gamma and binomial families, respec-
tively, as a function of physical inactivity (self-report of not spending ≥30 minutes in 
moderate physical activity ≥3 times per week). National population estimates were 
adjusted for demographics (age, gender, race, education, marital-status, income, 
region), payer (% coverage by public and/or private insurance), comorbidity severity 
(Deyo-Charlson index), complicating conditions (depression, diabetes, myocardial 
infarction, cerebrovascular accidents, heart failure, peripheral vascular disease), and 
antihypertensive treatment (classes). RESULTS: (reported as weighted estimates ± 
standard errors) Mean age (n = 46,884,259) was 60.8 ± 0.3 years; 23.4 ± 0.7% of 
patients had diabetes, and 13.9 ± 0.5% had depression. Some 52.8 ± 0.9% of patients 
reported being physically inactive. On average, patients had $8468 ± 257 in total, and 
$1453 ± 47 in out-of-pocket health care expenses in 2006 with 19.4 ± 0.6% having 
an emergency room visit and 16.0 ± 0.6% being hospitalized. Physical inactivity was 
associated with 26.0 ± 6.7% greater total and 18.5 ± 5.4% greater out-of-pocket 
health care expenses (both p < 0.00001). Physical inactivity also was associated with 
a 23.9 ± 12.4% increase in the odds of an emergency room visit (p = 0.032) and a 
38.4 ± 15.2% increase in the odds of a hospitalization (p = .003). CONCLUSIONS: 
We found strong associations between physical inactivity and greater health care 
expenditures and health care resource use in patients with hypertension. Further 
research is warranted to identify amenable barriers to physical activity in this 
population.
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OBJECTIVES: To estimate incremental health care expenditure associated with 
comorbid cardiovascular disease (CVD) among patients with chronic obstructive 
pulmonary disease (COPD) in the hospital setting. METHODS: Retrospective data 
derived from the 2007 National Inpatient Sample (NIS) of the Healthcare Cost Utiliza-
tion Project (HCUP) was analyzed. Hospital inpatient discharge records for patients 
with a primary diagnosis of COPD and who were ≥40 years of age; were extracted 
to form the study sample. The sample was then categorized into two groups based on 
whether there was a secondary diagnosis of CVD. Incremental health care expenditure 
due to comorbid CVD was then determined by comparing hospital charges among 
the two groups. In addition to hospital charges, national estimates of hospital length 
of stay (LOS) and in-hospital mortality were also examined and compared between 
the two groups. For patients with COPD and comorbid CVD, the outcomes were 
compared across the different CVDs (hypertension, heart failure, ischemic heart 
disease, pulmonary heart disease, cerebrovascular disease, and cardiomyopathy and 
dysarrythmia). RESULTS: Of the 114,812 COPD-related hospital discharges in 2007; 
78.23% (n = 89,822) had CVD listed as a secondary diagnosis. Mean hospital charges 
were $15,691(95% CI $14,943 $16,439) for patients with COPD and no comorbid 
CVD, and were $23,986 (95% CI $23,012.59 $24,959.22) for patients with COPD 
and CVD. Among COPD patients with comorbid CVD, the mean charges were highest 
for those with cardiomyopathy and dysarrythmia, at $25,359(95%CI$24,052.96 
$26,664.45). The mean LOS was also higher among COPD patients with comorbid 
CVD as compared to those without comorbid CVD (4.59 days vs. 4.16 days). The 
mean LOS was also longest for patients with cardiomyopathy and dysarrythmia at 
5.75 days. CONCLUSIONS: Health care expenditure due to comorbid CVD is sub-
stantial among hospitalized patients with COPD.
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OBJECTIVES: To understand community-based treatment in hypertension patients 
status, care-seeking behavior, medical care, cost burden, and analyze impact factors 
of their behavior and self-prevention and control effect, China Health Insurance 
Research Association developed a research on evaluation on drugs and medical cost 
of hypertension patients in China, and reduce the cost burden of those patients. 
METHODS: This study collected 1788 valid samples as well as structured question-
naire survey in 3 cities from retrospective study. A more comprehensive medical 
management and settlement model has provided through an integrated qualitative and 
quantitative data analysis. The data was analyzed by Spss12.0, discriminant analysis; 
Chi-square test, one-way MANOVA, and multivariate linear regression analysis. 
RESULTS: 1)80% outpatients’ cumulative frequency of patients with hypertension 
concentrates upon about 110 medicines and the spending in these 110 drugs cumu-
lated 75% of all Western medicine fees. The average cost of outpatients in western 
medicine was RMB 69.4 Yuan; Insurers spent about 97.2% of their premium revenues 
on patient medicine cost. 2)80% inpatients’ cumulative frequency of patients with 
hypertension concentrates upon about 100 medicines and the spending in these 100 
drugs cumulated 50% of all Western medicine fees. The average cost of inpatients in 
western medicine was RMB 35.1 Yuan; Insurers spent about 91.3% of their premium 
on inpatient medicine cost.3) Statistic analysis outcomes show that course of the 
disease(x1), the type of high blood pressure(x2), the numbers of complications(x3) and 
the types of Standard management(x4) have signiﬁcant inﬂuence on the total hyperten-
sion treatment fees. By multivariate linear regression analysis, a safe regression mode 
was reached as follows: y = 3936.51 + 1294.309*X3 − 1239.323*X4. CONCLU-
SIONS: The categories of drugs administrated by hypertension patients concentrate 
in large cities, the spending in drugs was lower and the proportion of claims was high. 
The standard based on community health centers can lower the cost of hypertension 
treatment.
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OBJECTIVES: Computed Tomography (CT) is widely used as a diagnostic tool for 
medical conditions of the head, chest, cardiac, pulmonary and abdominal system. The 
objective of this retrospective study was to identify predictors of CT scan use in 
emergency department (ED) of hospitals in the United States amongst patients suffer-
ing from Coronary Artery Disease (CAD). METHODS: ED component of National 
Hospital Ambulatory Medical Care Survey (NHAMCS) for years 2005 and 2006 was 
used for the analysis. Patients were identiﬁed based on chief complaint, physician 
diagnosis and discharge diagnosis for CAD by ICD 9 codes or reason for visit codes. 
The binary outcome variable was use of CT scan. Independent variables were selected 
based on available literature on utilization of health services and general demograph-
